F. Salmon

发表

Safety profile of recombinant adeno-associated viral vectors: focus on alipogene tiparvovec (Glybera®)

H. Petry, F. Salmon, K. Grosios, 2014, Expert review of clinical pharmacology.

Safety and liver transduction efficacy of rAAV5-cohPBGD in nonhuman primates: a potential therapy for acute intermittent porphyria.

C. von Kalle, J. Prieto, H. Petry, 2013, Human gene therapy.

Designing experiments for food-drug synergy: Health aspects

E. Schoen, J. Groten, V. Feron, 2006 .

Physiologically Based Pharmacokinetic Modeling of Cyclohexane as a Tool for Integrating Animal and Human Test Data

R. H. Mckee, L. Sweeney, H. Muijser, 2009, International journal of toxicology.

Chimeric Antigen Receptor-T Cell Therapy

M. Kersten, U. Jäger, J. Buechner, 2018, HemaSphere.

Use of fresh and cryopreserved hepatocytes to study the metabolism of pesticides in food-producing animals and rats.

F. Salmon, W. Kohl, 1996, Xenobiotica; the fate of foreign compounds in biological systems.

Model studies for evaluating the neurobehavioral effects of complex hydrocarbon solvents III. PBPK modeling of white spirit constituents as a tool for integrating animal and human test data.

R. H. Mckee, H. Muijser, A. Freidig, 2007, Neurotoxicology.

Immune Responses to AAV-Vectors, the Glybera Example from Bench to Bedside

H. Petry, Valérie Ferreira, F. Salmon, 2014, Front. Immunol..

The Use of Tissue Slices for Pharmacotoxicology Studies

P. H. Bach, Peter H. Bach, Eva Brittebo, 1996 .

A largely random AAV integration profile after LPLD gene therapy

Stephan Wolf, Raffaele Fronza, Hanno Glimm, 2013, Nature Medicine.

Reply to: NGS library preparation may generate artifactual integration sites of AAV vectors

Raffaele Fronza, Manfred Schmidt, Hanno Glimm, 2014, Nature Medicine.

Industry’s Giant Leap Into Cellular Therapy: Catalyzing Chimeric Antigen Receptor T Cell (CAR-T) Immunotherapy

D. Lebwohl, T. Taran, M. Leung, 2019, Current Hematologic Malignancy Reports.

Tisagenlecleucel Manufacturing Feasibility in Patients Less Than 3 Years of Age with Relapsed/Refractory Acute Lymphoblastic Leukemia

M. Robson, L. Eldjerou, J. Willert, 2019, Blood.

Safety and Efficacy of an Adeno Associated Virus-Based Vector Carrying the Human Clotting Factor IX Gene (AAV5-hFIX) As Studied in Non-Human Primates

J. Petersen, H. Petry, F. Salmon, 2014 .